[DOI] [PubMed] [Google Scholar] 26
Only 3.3% of patients on the higher dose stopped treatment because of GI-related side effects
To fufil this important evidentiary gap, the present analysis was conducted by focusing on GLP-1RAs approved
We treat your fur babies like our own
Both agents target glucose control and weight reduction through different mechanismssemaglutide via appetite suppression and berberine via insulin sensitivity

Rare: may affect up to 1 in 1,000 people Acniform and bullous eruptions (acne-like and blistery skin eruptions) Not known: frequency cannot be estimated from the available data Headache, dizziness Nausea (feeling sick), vomiting, diarrhoea Malaise (feeling unwell) Rash, itching Injection site reactions including injection site pain, injection site erythema, injection site pruritus, injection site induration, and injection site swelling (Reactions at the site of the injection) Exanthema (a widespread skin rash) Chromaturia (unusual coloured urine) Fever Hot flushes (a feeling of intense heat with sweating and rapid heartbeat) Chills (feeling of coldness accompanied by shivering) Paraesthesia (feeling of pins and needles) Tremor (tremble or shakes) Hypokalaemia (decreased potassium levels in the blood) Reactive thrombocytosis (body produces too many platelets) Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse